WELL Welltower Inc

Welltower is a healthcare infrastructure REIT owning senior housing, outpatient medical, and post-acute care facilities, operating at the intersection of real estate and healthcare services. Sector: Real Estate.

Welltower Inc (WELL) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

Examining the company through a capital allocation lens, ROIC is 0.77%, WACC is 8.18%, and the economic spread is -7.41%. On balance, the economic spread is negative, indicating that at current return levels, reinvestment is value-destructive in aggregate. Supporting metrics show ROE at 2.55% and ROA at 1.09%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company that likely needs operating improvement before returns quality can be considered durable.

Multiple analysis puts the company at trailing P/E of 144.54, forward P/E of 71.90, PEG of 316.29. The spread from trailing to forward multiple is wide enough to suggest earnings momentum is a meaningful part of the current valuation case. Growth-adjusted, the company is priced at a premium — a level that demands consistent execution and limits the potential for multiple expansion from here. The aggregate current ratio of 3.52 reflects a company with strong liquidity buffers against short-term stress. The combined valuation and liquidity profile points to a company where current prices embed meaningful growth expectations, and where delivery against those expectations will drive the return outcome.

From gross to free cash flow, gross margin sits at 39.70%, operating margin at 4.09%, and free cash flow margin at 26.70%. At this gross margin level, pricing power is present but not dominant — cost management matters as much as revenue growth. At this level, operating margins signal that earnings quality is limited — a feature of growth-stage or restructuring businesses. At this level, FCF margins reflect a company with genuine capital efficiency and strong cash-based earnings quality. The margin profile is mixed, with some layers more resilient than others and less room for execution slippage.

Combining revenue momentum with analyst targets, the estimated 12-month price change of 12.36%, where consensus expectations favor gradual appreciation over the next year, while TTM revenue growth of 41.33% reflecting top-line acceleration that, if sustained, supports the forward earnings case. Separating operating reality from market-implied expectations is useful here — they can diverge meaningfully when sentiment shifts. The forward return case hinges on whether the operating reality stays close enough to analyst assumptions for those targets to remain credible. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

The composite read is moderately constructive but uneven — in the absence of a clear catalyst, a neutral stance is well-supported by the data.

The analysis above draws from quantitative data only and does not constitute personalized financial advice. Investors should conduct independent research and consider professional guidance before acting on any information presented here.